Please join us for a global WHO webinar on 25 March 2026 showcasing the latest DHIS2 packages for HIV, tuberculosis, viral hepatitis and sexually transmitted infections (STIs). This is built on WHO standards to support stronger routine data systems, surveillance, and program decision-making.
The session will feature technical overviews of the updated TB and HIV/Hepatitis/STI trackers, live demonstrations, country experience sharing, and a panel discussion on strengthening case surveillance and measuring impact, followed by Q&A.
Date, times and registration
25 March 2026 | 09:00–10:30 (CET) | Register here
and
25 March 2026 | 14:00–15:30 (CET) | Register here
The webinar will be held in English, with interpretation in French, Spanish and Russian.
Webinar objectives
- to provide a technical overview of WHO guidance for the surveillance of TB, HIV, hepatitis and STIs;
- to showcase updated WHO DHIS2 packages for the surveillance of TB, HIV, hepatitis and STIs, highlighting their alignment with WHO guidance; and
- to discuss strategic considerations for strengthening disease surveillance, focusing on measuring impact.
Key speakers
- Anh Chu, Technical Officer, Management Information Systems, Department for Data, Digital Health, Analytics and AI, WHO, Switzerland
- Marek Lalli, Technical Officer, Surveillance and Programmatic Use of Data, Department for HIV, TB, Hepatitis and STIs, WHO, Switzerland
- Shona Dalal, Technical Officer, Surveillance and Programmatic Use of Data, Department for HIV, TB, Hepatitis and STIs, WHO, Switzerland
- Stefano Perotti, DHIS2 Implementer, University of Oslo, Norway
- Yury Rogachev, DHIS2 Implementer, University of Oslo, Norway
- Guy Stallworthy, TB Financing and Sustainability, Global Health Division, The Gates Foundation, United States of America
- Michelle Monroe, Senior Specialist, Technical Advice and Partnerships Department, The Global Fund, Switzerland
- Casimir Manzengo Mingiedi, Medical Officer, HIV, TB, STIs, Hepatitis Programme, WHO African Regional Office, Multi-Country Assignment Team, Burkina Faso
Moderator
- Charalampos (Babis) Sismanidis, Team Lead, Surveillance and Programmatic Use of Data, Department for HIV, TB, Hepatitis and STIs, WHO, Switzerland
Background
As the public health response to HIV, TB, viral hepatitis and STIs intensifies its focus on closing persistent gaps in prevention, testing and treatment, the need for smarter, more responsive data systems has never been greater. An evolution in the underlying routine data systems is needed to identify epidemiological patterns and service gaps, and accelerate targeted high impact interventions. The rapid expansion in health data and its critical role in decision making requires sustained strategic investment in digital systems. The transition from paper-based to digital systems offers opportunities to greatly improve patient-centred care and global health.
To support this transformation, WHO released strategic information and surveillance guidance on HIV, TB, viral hepatitis and STIs, which focuses on the collection and use of data across prevention, testing and treatment, to longer-term health care. These resources present a standard minimum dataset, priority indicators and recommendations to strengthen surveillance and programmatic use of data.
WHO has also released data software packages for HIV, TB, viral hepatitis and STIs based on WHO standards and policy guidance using the free and open-source District Health Information System 2 (DHIS2) software platform. Specific DHIS2 Trackers for TB as well as for HIV case surveillance and HIV prevention (both of which include modules for hepatitis and STIs), are designed to record individual-level and longitudinal data. New updates and packages are available for TB, HIV and hepatitis.